Spera Nexus, Inc.

CategoryCPhI
Booth No.1D-18
Pavilion
In June 2021, the fine chemical businesses of Iwaki Co., Ltd. and Iwaki Pharmaceutical Co., Ltd. joined together to form a company named Spera Nexus, Inc.
We offer a wide range of services related to pharmaceuticals, from APIs to formulations, by combining the globally accepted and reliable technological capabilities of our group company, SperaPharma, with the peptide synthesis technology of JITSUBO.

Corporate information

Address 103-0023
4-8-2, Nihombashi, Honcho, Chuo-ku, Tokyo JAPAN
TEL +81-3-3279-0454
FAX +81-3-3279-0410
URL https://www.spera-nexus.co.jp/en/
Email tamegai.hi@spera-nexus.co.jp
Product Classification Cetirizine hydrochloride
Levocetirizine hydrochloride
Selexipag
Adapalene
Apremilast
Ufenamate
Ezetimibe
Eszopiclone
Olopatadine hydrochloride
Guanfacine hydrochloride
Celecoxib
Zonisamide
Tadalafil
Tamsulosin hydrochloride
Tulobuterol
Bisacodyl
Fingolimod hydrochloride
Propiverine hydrochloride
Mesalazine
Montelukast sodium

Exhibitor Presentation

    April 21(Thu.) 10:30-11:00 【1B】
    Manufacturing equipment for High Potency API and contract manufacturing at Shizuoka Plant